Your browser is no longer supported. Please, upgrade your browser.
Insulet Corporation
Index- P/E2659.10 EPS (ttm)0.10 Insider Own0.30% Shs Outstand65.95M Perf Week1.98%
Market Cap17.81B Forward P/E150.40 EPS next Y1.77 Insider Trans-23.07% Shs Float65.72M Perf Month-0.48%
Income6.80M PEG- EPS next Q0.07 Inst Own98.50% Short Float2.94% Perf Quarter5.74%
Sales904.40M P/S19.70 EPS this Y-44.60% Inst Trans-0.51% Short Ratio4.35 Perf Half Y24.06%
Book/sh9.15 P/B29.06 EPS next Y78.77% ROA0.40% Target Price280.31 Perf Year46.50%
Cash/sh14.10 P/C18.85 EPS next 5Y- ROE1.50% 52W Range121.00 - 298.43 Perf YTD4.02%
Dividend- P/FCF- EPS past 5Y15.90% ROI2.90% 52W High-10.90% Beta0.66
Dividend %- Quick Ratio5.30 Sales past 5Y27.90% Gross Margin64.40% 52W Low119.76% ATR12.59
Employees1900 Current Ratio6.00 Sales Q/Q17.50% Oper. Margin5.70% RSI (14)46.64 Volatility5.69% 4.05%
OptionableYes Debt/Eq1.75 EPS Q/Q-434.20% Profit Margin0.80% Rel Volume0.67 Prev Close265.91
ShortableYes LT Debt/Eq1.73 EarningsFeb 23 AMC Payout0.00% Avg Volume443.58K Price265.91
Recom2.50 SMA20-2.87% SMA50-1.05% SMA20014.83% Volume0 Change0.00%
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $260
Dec-16-20Downgrade Citigroup Buy → Neutral $255 → $268
Jul-28-20Initiated Wells Fargo Overweight $231
Apr-24-20Downgrade SVB Leerink Outperform → Mkt Perform
Apr-03-20Initiated BofA/Merrill Neutral $200
Mar-31-20Downgrade Berenberg Buy → Hold
Mar-05-20Initiated Citigroup Buy $220
Dec-10-19Initiated CFRA Sell $163
Oct-23-19Initiated Stifel Hold
Oct-18-19Downgrade Canaccord Genuity Buy → Hold $135 → $145
Oct-14-19Downgrade BTIG Research Buy → Neutral
Oct-04-19Downgrade UBS Buy → Neutral $155 → $160
Oct-03-19Downgrade Guggenheim Buy → Neutral
Aug-06-19Upgrade JP Morgan Neutral → Overweight $120 → $155
Jun-10-19Downgrade Northland Capital Outperform → Market Perform
May-06-19Upgrade BTIG Research Neutral → Buy $115
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
Jan-08-18Upgrade Raymond James Mkt Perform → Outperform
Nov-03-17Upgrade Canaccord Genuity Hold → Buy $50 → $65
Feb-24-21 04:11PM  
Feb-23-21 10:30PM  
Feb-10-21 04:44AM  
Feb-08-21 04:01PM  
Jan-19-21 09:56AM  
Jan-18-21 06:00AM  
Jan-11-21 06:00AM  
Jan-07-21 01:18PM  
Dec-24-20 03:05AM  
Dec-23-20 12:11PM  
Dec-21-20 11:36AM  
Dec-04-20 11:31AM  
Nov-24-20 02:19PM  
Nov-09-20 04:01PM  
Nov-05-20 10:07AM  
Nov-04-20 08:31PM  
Nov-02-20 06:00AM  
Oct-29-20 06:00AM  
Oct-28-20 12:32PM  
Oct-26-20 09:25PM  
Oct-22-20 10:43AM  
Oct-20-20 04:01PM  
Oct-14-20 01:42PM  
Oct-13-20 09:07AM  
Oct-12-20 01:28PM  
Oct-05-20 06:00AM  
Oct-01-20 09:21AM  
Sep-21-20 11:25AM  
Sep-07-20 05:14PM  
Sep-05-20 11:31AM  
Sep-01-20 02:56PM  
Aug-25-20 10:44AM  
Aug-24-20 06:00AM  
Aug-12-20 03:04PM  
Aug-10-20 11:31AM  
Aug-06-20 05:25PM  
Jul-30-20 12:34PM  
Jul-13-20 05:04PM  
Jul-06-20 04:03PM  
Jun-30-20 12:23PM  
Jun-29-20 06:00AM  
Jun-24-20 06:00AM  
Jun-21-20 11:13AM  
Jun-12-20 08:58AM  
Jun-11-20 06:00AM  
Jun-05-20 06:00AM  
Jun-03-20 06:45AM  
May-31-20 10:05PM  
May-28-20 04:01PM  
May-23-20 07:28AM  
May-14-20 03:45PM  
May-12-20 09:26PM  
May-11-20 10:39AM  
May-09-20 01:31PM  
May-08-20 10:55AM  
May-07-20 05:55PM  
May-06-20 09:07AM  
May-04-20 04:55PM  
May-03-20 01:43PM  
May-01-20 04:33PM  
Apr-30-20 12:34PM  
Apr-29-20 01:12PM  
Apr-23-20 10:55AM  
Apr-16-20 06:00AM  
Apr-13-20 12:47PM  
Apr-06-20 07:00AM  
Mar-26-20 11:30AM  
Mar-25-20 09:57AM  
Mar-22-20 11:03AM  
Mar-20-20 07:43AM  
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petrovic ShaceyPresident and CEOJan 04Option Exercise30.5815,000458,70036,535Jan 05 04:37 PM
Petrovic ShaceyPresident and CEOJan 04Sale250.6115,0003,759,15021,535Jan 05 04:37 PM
Petrovic ShaceyPresident and CEODec 18Option Exercise29.263,41799,98122,230Dec 21 04:34 PM
Lemoine David ADirectorNov 17Sale250.711,000250,7106,977Nov 18 04:17 PM
Fallon John A.DirectorNov 04Option Exercise28.873,00086,61017,498Nov 06 04:05 PM
Fallon John A.DirectorNov 04Sale230.003,000690,00014,498Nov 06 04:05 PM
Fallon John A.DirectorNov 02Option Exercise35.114,000140,44018,498Nov 03 04:05 PM
Fallon John A.DirectorNov 02Sale225.004,000900,00014,498Nov 03 04:05 PM
Spears Michael PSVP, RA and ComplianceOct 09Option Exercise29.6322,257659,38331,204Oct 13 04:20 PM
Spears Michael PSVP, RA and ComplianceOct 09Sale246.1022,2575,477,4488,947Oct 13 04:20 PM
Petrovic ShaceyPresident and CEOOct 05Option Exercise30.5815,000458,70033,813Oct 07 04:14 PM
Petrovic ShaceyPresident and CEOOct 05Sale233.9115,0003,508,65018,813Oct 07 04:14 PM
Alpuche CharlesEVP & Chief Operating OfficerSep 01Sale220.113,415751,67641,257Sep 02 04:36 PM
Christensen BretEVP and CCOAug 12Sale201.545,0001,007,70013,700Aug 13 04:36 PM
Benjamin EricSVP, Innovation and StrategyJul 23Option Exercise29.398,392246,61117,096Jul 24 04:24 PM
Benjamin EricSVP, Innovation and StrategyJul 23Sale210.0014,9123,131,5208,704Jul 24 04:24 PM
Nevinny Corinne HDirectorMay 01Sale196.82863169,8563,254May 04 04:26 PM
Nevinny Corinne HDirectorApr 30Sale195.54796155,6504,117May 04 04:26 PM
Spears Michael PSVP, RA and ComplianceApr 16Sale193.761,449280,75811,447Apr 20 03:59 PM
Lemoine David ADirectorMar 06Sale177.491,042184,9456,948Mar 10 04:54 PM